NASDAQ:NCTY The9 (NCTY) Stock Price, News & Analysis → The Next Nvidia? (From InvestorPlace) (Ad) Free NCTY Stock Alerts $7.71 -0.27 (-3.38%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$7.70▼$7.9350-Day Range$4.76▼$7.9852-Week Range$3.33▼$14.70Volume38,475 shsAverage Volume26,361 shsMarket Capitalization$36.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get The9 alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About The9 Stock (NASDAQ:NCTY)The9 Limited, together with its subsidiaries, operates as Internet company in the People's Republic of China and internationally. It also involves in the operation of cryptocurrency mining and Non-Fungible Token platform NFTSTAR, a NFT trading and community platform that provides users with purchase, trade, and interactive activities. The company was formerly known as GameNow.net Limited and changed its name to The9 Limited in February 2004. The9 Limited was incorporated in 1999 and is headquartered in Shanghai, the People's Republic of China.Read More NCTY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NCTY Stock News HeadlinesApril 25, 2024 | americanbankingnews.comThe9 (NASDAQ:NCTY) Stock Price Crosses Above 200-Day Moving Average of $6.16April 18, 2024 | finance.yahoo.comThe9 Full Year 2023 Earnings: CN¥40.61 loss per share (vs CN¥406 loss in FY 2022)May 5, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 15, 2024 | prnewswire.comThe9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023April 15, 2024 | finanznachrichten.deThe9 Limited: A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is BornApril 10, 2024 | msn.comSolar, Telecoms Stocks Pull Asian Equities Traded in the US as American Depositary Receipts Lower on WednesdayMarch 26, 2024 | msn.comAsian Equities Traded in the US as American Depositary Receipts Flat in Tuesday TradingMarch 26, 2024 | finance.yahoo.comThe9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM TherapeuticMay 5, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)March 26, 2024 | markets.businessinsider.comThe9 To Own 30% Of WM Therapeutic - Quick FactsMarch 26, 2024 | finance.yahoo.com/C O R R E C T I O N -- The9 Limited/March 5, 2024 | finanznachrichten.deThe9 Limited: The9 Signed a Legally Binding Term Sheet to Acquire a Leading AIGC Driven Digital Human SaaS Platform ShenMaMarch 5, 2024 | finance.yahoo.comThe9 Signed a Legally Binding Term Sheet to Acquire a Leading AIGC Driven Digital Human SaaS Platform ShenMaFebruary 21, 2024 | prnewswire.comThe9 Signed a Legally Binding Term Sheet with a Leading AI SaaS Legal Service Platform 365LAWHELP.COMFebruary 21, 2024 | markets.businessinsider.comThe9 To Purchase 19% Shares Of Fazhidao - Quick FactsFebruary 21, 2024 | finance.yahoo.comThe9 Signed a Legally Binding Term Sheet with a Leading AI SaaS Legal Service Platform 365LAWHELP.COMFebruary 21, 2024 | prnewswire.comThe9 Signed a Legally Binding Term Sheet with a Leading AI SaaS Legal Service Platform 365LAWHELP.COMJanuary 19, 2024 | marketwatch.comThe9 Limited CEO to Buy Up to 10% of Company's ADSsJanuary 19, 2024 | markets.businessinsider.comThe9 CEO To Buy 10% Of Company ADSs; Stock Up In Pre-marketJanuary 19, 2024 | finance.yahoo.comThe9's Chairman and CEO to Purchase No More Than 10% of The9 ADSs in the Open MarketDecember 29, 2023 | msn.comAREN, CXDO among major communication services gainers; NCTY, LPTV among losersDecember 21, 2023 | msn.comMSGM, DRCT among major communication services gainers; NCTY, SGA among losersNovember 30, 2023 | marketwatch.comThe9 Shares Rise 12% After Private PlacementNovember 30, 2023 | finance.yahoo.comThe9 Limited Raised US$12 million in a Private Placement Transaction to Fund Business GrowthNovember 17, 2023 | finance.yahoo.comThe9 Limited to Hold Annual General Meeting on December 22, 2023October 24, 2023 | benzinga.com9 Communication Services Stocks Moving In Tuesday's Pre-Market SessionOctober 5, 2023 | msn.comFinancial Stocks Help Lift Asian Equities Traded in the US as American Depositary Receipts Early ThursdaySee More Headlines Receive NCTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for The9 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/05/2024Next Earnings (Estimated)5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Nondepository credit institutions Sub-IndustryN/A Current SymbolNASDAQ:NCTY CUSIPN/A CIK1296774 Webwww.the9.com Phone862161086080Fax86-21-5172-9903Employees72Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.09 Current Ratio1.37 Quick Ratio1.37 Sales & Book Value Annual Sales$25.22 million Price / Sales1.44 Cash FlowN/A Price / Cash FlowN/A Book Value$5.43 per share Price / Book1.42Miscellaneous Outstanding Shares4,700,000Free Float3,253,000Market Cap$36.24 million OptionableOptionable Beta1.88 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Jun Zhu (Age 57)Co-Founder, Chairman & CEO Mr. Kwok Ho Lai (Age 47)CFO & Director Wendy WengManager of Investor RelationsKey CompetitorsMawson Infrastructure GroupNASDAQ:MIGISphere 3DNASDAQ:ANYALJ RegionalNASDAQ:ALJJExela TechnologiesNASDAQ:XELASenmiao TechnologyNASDAQ:AIHSView All Competitors NCTY Stock Analysis - Frequently Asked Questions How have NCTY shares performed in 2024? The9's stock was trading at $7.49 at the beginning of the year. Since then, NCTY shares have increased by 2.9% and is now trading at $7.71. View the best growth stocks for 2024 here. Are investors shorting The9? The9 saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 52,000 shares, a decrease of 20.2% from the March 31st total of 65,200 shares. Based on an average daily volume of 51,300 shares, the short-interest ratio is currently 1.0 days. Approximately 1.8% of the company's stock are short sold. View The9's Short Interest. When is The9's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our NCTY earnings forecast. When did The9's stock split? The9's stock reverse split on Monday, October 2nd 2023. The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of The9 own? Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Gevo (GEVO), Biocept (BIOC), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), Acasti Pharma (ACST), Anavex Life Sciences (AVXL), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and Jaguar Health (JAGX). How do I buy shares of The9? Shares of NCTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NCTY) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The9 Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.